Plain-English translation of NCT06814431 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at whether people with Parkinson's disease who carry a particular change in the GBA1 gene have a different risk of developing cancer compared to people with Parkinson's disease without this genetic change. Researchers will gather information from about 3,000 Parkinson's disease patients across Italy and check cancer registries to see who has been diagnosed with cancer over time.
Some genetic changes may increase the risk of certain cancers in people with Parkinson's disease, but doctors don't yet have clear answers about which patients are at higher risk. This study aims to provide those answers so doctors can better monitor and care for their Parkinson's disease patients.
You likely qualify if…
You likely don't qualify if…
You would not need to attend visits or take any new medication. Instead, researchers would work with your doctor and local health authorities to collect information about your Parkinson's disease diagnosis and whether you have developed cancer. This involves accessing your existing medical records and cancer registry data, so your participation is mostly passive — the research team does the work of gathering the information.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
Italy